Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study

Aim This study aims to examine the real‐world effectiveness of education regarding clinical guidelines for psychiatric disorders using ‘the Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)’ project. Methods The EGUIDE project is a nationwide prospective i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychiatry and clinical neurosciences 2023-10, Vol.77 (10), p.559-568
Hauptverfasser: Hasegawa, Naomi, Yasuda, Yuka, Yasui‐Furukori, Norio, Yamada, Hisashi, Hori, Hikaru, Ichihashi, Kayo, Takaesu, Yoshikazu, Iida, Hitoshi, Muraoka, Hiroyuki, Kodaka, Fumitoshi, Iga, Jun‐ichi, Hashimoto, Naoki, Ogasawara, Kazuyoshi, Ohi, Kazutaka, Fukumoto, Kentaro, Numata, Shusuke, Tsuboi, Takashi, Usami, Masahide, Hishimoto, Akitoyo, Furihata, Ryuji, Kishimoto, Taishiro, Nakamura, Toshinori, Katsumoto, Eiichi, Ochi, Shinichiro, Nagasawa, Tatsuya, Atake, Kiyokazu, Kubota, Chika, Komatsu, Hiroshi, Yamagata, Hirotaka, Ide, Kenta, Takeshima, Masahiro, Kido, Mikio, Kikuchi, Saya, Okada, Tsuyoshi, Matsumoto, Junya, Miura, Kenichiro, Shimazu, Taichi, Inada, Ken, Watanabe, Koichiro, Hashimoto, Ryota
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 568
container_issue 10
container_start_page 559
container_title Psychiatry and clinical neurosciences
container_volume 77
creator Hasegawa, Naomi
Yasuda, Yuka
Yasui‐Furukori, Norio
Yamada, Hisashi
Hori, Hikaru
Ichihashi, Kayo
Takaesu, Yoshikazu
Iida, Hitoshi
Muraoka, Hiroyuki
Kodaka, Fumitoshi
Iga, Jun‐ichi
Hashimoto, Naoki
Ogasawara, Kazuyoshi
Ohi, Kazutaka
Fukumoto, Kentaro
Numata, Shusuke
Tsuboi, Takashi
Usami, Masahide
Hishimoto, Akitoyo
Furihata, Ryuji
Kishimoto, Taishiro
Nakamura, Toshinori
Katsumoto, Eiichi
Ochi, Shinichiro
Nagasawa, Tatsuya
Atake, Kiyokazu
Kubota, Chika
Komatsu, Hiroshi
Yamagata, Hirotaka
Ide, Kenta
Takeshima, Masahiro
Kido, Mikio
Kikuchi, Saya
Okada, Tsuyoshi
Matsumoto, Junya
Miura, Kenichiro
Shimazu, Taichi
Inada, Ken
Watanabe, Koichiro
Hashimoto, Ryota
description Aim This study aims to examine the real‐world effectiveness of education regarding clinical guidelines for psychiatric disorders using ‘the Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)’ project. Methods The EGUIDE project is a nationwide prospective implementation study of two clinical practice guidelines, i.e., the Guideline for Pharmacological Therapy of Schizophrenia and the Treatment Guidelines for Major Depressive Disorders, in Japan. Between 2016 and 2019, 782 psychiatrists belonging to 176 hospitals with psychiatric wards participated in the project and attended lectures on clinical practice guidelines. The proportions of guideline‐recommended treatments in 7405 patients with schizophrenia and 3794 patients with major depressive disorder at participating hospitals were compared between patients under the care of psychiatrists participating in the project and those not participating in the project. Clinical and prescribing data on the patients discharged from April to September each year from participating hospitals of the project were also analyzed. Results The proportions of three quality indicators (antipsychotic monotherapy regardless of whether other psychotropics medication, antipsychotic monotherapy without other psychotropics and no prescription of anxiolytics or hypnotics) for schizophrenia were higher among participating psychiatrists than among nonparticipating psychiatrists. As similar results were obtained in major depressive disorder, the effectiveness of the project for the dissemination of guideline‐recommended treatment has been replicated. Conclusion This strategy of providing education regarding the clinical guidelines for psychiatric disorders was effective in improving the treatment‐related behavior of psychiatrists. The use of this education‐based strategy might contribute to resolving the mental health treatment gap.
doi_str_mv 10.1111/pcn.13578
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11488608</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2863294868</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5548-b615fca94941a3b6e943133bd1480c9306d7a549656a672718d7b449bf0b067e3</originalsourceid><addsrcrecordid>eNp1kc9uFSEYxSdGY2t14QsYEje6mBYGBhg3TXNT_ySNutA1YeCbOzRzYQSm5voavrCMtzbVREICCb9zvkNOVT0n-JSUdTYbf0poK-SD6pgwhmsiSfew3GlDa0IJP6qepHSNMaaUk8fVERVcMkHIcfXzchjAZBQGBHYxOrvgUYStjtb5LcoRdN6Bz2i7OAuT85DQECJKZnQ_wjxG8E4j7S2yMEdIadWXnUe4J-5h1DeuyMqYOe2LVufoUk5v0AXaLVN2pmBQbPNi90-rR4OeEjy7PU-qr28vv2ze11ef3n3YXFzVpm2ZrHtO2sHojnWMaNpz6BgllPaWMIlNRzG3Qres4y3XXDSCSCt6xrp-wD3mAuhJdX7wnZd-B3aNEPWk5uh2Ou5V0E79_eLdqLbhRpEyQXIsi8OrW4cYvi2Qstq5ZGCatIewJNVITpuOSb6iL_9Br8MSfflfoUSDBcFypV4fKBNDShGGuzQEq7VrVbpWv7su7Iv78e_IP-UW4OwAfHcT7P_vpD5vPh4sfwFWfbaj</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2872071088</pqid></control><display><type>article</type><title>Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Open Access Titles of Japan</source><source>Wiley Online Library (Open Access Collection)</source><creator>Hasegawa, Naomi ; Yasuda, Yuka ; Yasui‐Furukori, Norio ; Yamada, Hisashi ; Hori, Hikaru ; Ichihashi, Kayo ; Takaesu, Yoshikazu ; Iida, Hitoshi ; Muraoka, Hiroyuki ; Kodaka, Fumitoshi ; Iga, Jun‐ichi ; Hashimoto, Naoki ; Ogasawara, Kazuyoshi ; Ohi, Kazutaka ; Fukumoto, Kentaro ; Numata, Shusuke ; Tsuboi, Takashi ; Usami, Masahide ; Hishimoto, Akitoyo ; Furihata, Ryuji ; Kishimoto, Taishiro ; Nakamura, Toshinori ; Katsumoto, Eiichi ; Ochi, Shinichiro ; Nagasawa, Tatsuya ; Atake, Kiyokazu ; Kubota, Chika ; Komatsu, Hiroshi ; Yamagata, Hirotaka ; Ide, Kenta ; Takeshima, Masahiro ; Kido, Mikio ; Kikuchi, Saya ; Okada, Tsuyoshi ; Matsumoto, Junya ; Miura, Kenichiro ; Shimazu, Taichi ; Inada, Ken ; Watanabe, Koichiro ; Hashimoto, Ryota</creator><creatorcontrib>Hasegawa, Naomi ; Yasuda, Yuka ; Yasui‐Furukori, Norio ; Yamada, Hisashi ; Hori, Hikaru ; Ichihashi, Kayo ; Takaesu, Yoshikazu ; Iida, Hitoshi ; Muraoka, Hiroyuki ; Kodaka, Fumitoshi ; Iga, Jun‐ichi ; Hashimoto, Naoki ; Ogasawara, Kazuyoshi ; Ohi, Kazutaka ; Fukumoto, Kentaro ; Numata, Shusuke ; Tsuboi, Takashi ; Usami, Masahide ; Hishimoto, Akitoyo ; Furihata, Ryuji ; Kishimoto, Taishiro ; Nakamura, Toshinori ; Katsumoto, Eiichi ; Ochi, Shinichiro ; Nagasawa, Tatsuya ; Atake, Kiyokazu ; Kubota, Chika ; Komatsu, Hiroshi ; Yamagata, Hirotaka ; Ide, Kenta ; Takeshima, Masahiro ; Kido, Mikio ; Kikuchi, Saya ; Okada, Tsuyoshi ; Matsumoto, Junya ; Miura, Kenichiro ; Shimazu, Taichi ; Inada, Ken ; Watanabe, Koichiro ; Hashimoto, Ryota</creatorcontrib><description>Aim This study aims to examine the real‐world effectiveness of education regarding clinical guidelines for psychiatric disorders using ‘the Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)’ project. Methods The EGUIDE project is a nationwide prospective implementation study of two clinical practice guidelines, i.e., the Guideline for Pharmacological Therapy of Schizophrenia and the Treatment Guidelines for Major Depressive Disorders, in Japan. Between 2016 and 2019, 782 psychiatrists belonging to 176 hospitals with psychiatric wards participated in the project and attended lectures on clinical practice guidelines. The proportions of guideline‐recommended treatments in 7405 patients with schizophrenia and 3794 patients with major depressive disorder at participating hospitals were compared between patients under the care of psychiatrists participating in the project and those not participating in the project. Clinical and prescribing data on the patients discharged from April to September each year from participating hospitals of the project were also analyzed. Results The proportions of three quality indicators (antipsychotic monotherapy regardless of whether other psychotropics medication, antipsychotic monotherapy without other psychotropics and no prescription of anxiolytics or hypnotics) for schizophrenia were higher among participating psychiatrists than among nonparticipating psychiatrists. As similar results were obtained in major depressive disorder, the effectiveness of the project for the dissemination of guideline‐recommended treatment has been replicated. Conclusion This strategy of providing education regarding the clinical guidelines for psychiatric disorders was effective in improving the treatment‐related behavior of psychiatrists. The use of this education‐based strategy might contribute to resolving the mental health treatment gap.</description><identifier>ISSN: 1323-1316</identifier><identifier>ISSN: 1440-1819</identifier><identifier>EISSN: 1440-1819</identifier><identifier>DOI: 10.1111/pcn.13578</identifier><identifier>PMID: 37684711</identifier><language>eng</language><publisher>Melbourne: John Wiley &amp; Sons Australia, Ltd</publisher><subject>Antipsychotic Agents - therapeutic use ; Antipsychotics ; Anxiolytics ; Clinical medicine ; clinical practice guideline ; Clinical practice guidelines ; Depression ; Depressive Disorder, Major - drug therapy ; dissemination ; education ; Hospitals ; Humans ; Hypnotics ; major depressive disorder ; Mental depression ; Mental disorders ; Patients ; Prospective Studies ; Psychiatrists ; Psychiatry ; Psychotropic drugs ; Psychotropic Drugs - therapeutic use ; Regular ; Schizophrenia ; Schizophrenia - drug therapy</subject><ispartof>Psychiatry and clinical neurosciences, 2023-10, Vol.77 (10), p.559-568</ispartof><rights>2023 The Authors. published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.</rights><rights>2023 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5548-b615fca94941a3b6e943133bd1480c9306d7a549656a672718d7b449bf0b067e3</citedby><cites>FETCH-LOGICAL-c5548-b615fca94941a3b6e943133bd1480c9306d7a549656a672718d7b449bf0b067e3</cites><orcidid>0000-0002-3722-7837 ; 0000-0002-8253-8888 ; 0000-0001-8311-7148 ; 0000-0002-4414-3770 ; 0000-0002-9169-3249 ; 0000-0003-4228-3208 ; 0000-0002-3073-4588 ; 0000-0002-1145-9971 ; 0000-0002-2746-1590 ; 0000-0003-0614-7524 ; 0000-0002-0736-7070 ; 0000-0001-9417-4391 ; 0000-0003-2263-3477 ; 0000-0002-0809-2697 ; 0000-0002-5941-4238 ; 0000-0001-9577-9640 ; 0000-0001-8129-4220 ; 0000-0003-4409-3096 ; 0000-0002-2240-5290</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fpcn.13578$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fpcn.13578$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,315,782,786,887,1419,1435,27931,27932,45581,45582,46416,46840</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37684711$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hasegawa, Naomi</creatorcontrib><creatorcontrib>Yasuda, Yuka</creatorcontrib><creatorcontrib>Yasui‐Furukori, Norio</creatorcontrib><creatorcontrib>Yamada, Hisashi</creatorcontrib><creatorcontrib>Hori, Hikaru</creatorcontrib><creatorcontrib>Ichihashi, Kayo</creatorcontrib><creatorcontrib>Takaesu, Yoshikazu</creatorcontrib><creatorcontrib>Iida, Hitoshi</creatorcontrib><creatorcontrib>Muraoka, Hiroyuki</creatorcontrib><creatorcontrib>Kodaka, Fumitoshi</creatorcontrib><creatorcontrib>Iga, Jun‐ichi</creatorcontrib><creatorcontrib>Hashimoto, Naoki</creatorcontrib><creatorcontrib>Ogasawara, Kazuyoshi</creatorcontrib><creatorcontrib>Ohi, Kazutaka</creatorcontrib><creatorcontrib>Fukumoto, Kentaro</creatorcontrib><creatorcontrib>Numata, Shusuke</creatorcontrib><creatorcontrib>Tsuboi, Takashi</creatorcontrib><creatorcontrib>Usami, Masahide</creatorcontrib><creatorcontrib>Hishimoto, Akitoyo</creatorcontrib><creatorcontrib>Furihata, Ryuji</creatorcontrib><creatorcontrib>Kishimoto, Taishiro</creatorcontrib><creatorcontrib>Nakamura, Toshinori</creatorcontrib><creatorcontrib>Katsumoto, Eiichi</creatorcontrib><creatorcontrib>Ochi, Shinichiro</creatorcontrib><creatorcontrib>Nagasawa, Tatsuya</creatorcontrib><creatorcontrib>Atake, Kiyokazu</creatorcontrib><creatorcontrib>Kubota, Chika</creatorcontrib><creatorcontrib>Komatsu, Hiroshi</creatorcontrib><creatorcontrib>Yamagata, Hirotaka</creatorcontrib><creatorcontrib>Ide, Kenta</creatorcontrib><creatorcontrib>Takeshima, Masahiro</creatorcontrib><creatorcontrib>Kido, Mikio</creatorcontrib><creatorcontrib>Kikuchi, Saya</creatorcontrib><creatorcontrib>Okada, Tsuyoshi</creatorcontrib><creatorcontrib>Matsumoto, Junya</creatorcontrib><creatorcontrib>Miura, Kenichiro</creatorcontrib><creatorcontrib>Shimazu, Taichi</creatorcontrib><creatorcontrib>Inada, Ken</creatorcontrib><creatorcontrib>Watanabe, Koichiro</creatorcontrib><creatorcontrib>Hashimoto, Ryota</creatorcontrib><title>Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study</title><title>Psychiatry and clinical neurosciences</title><addtitle>Psychiatry Clin Neurosci</addtitle><description>Aim This study aims to examine the real‐world effectiveness of education regarding clinical guidelines for psychiatric disorders using ‘the Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)’ project. Methods The EGUIDE project is a nationwide prospective implementation study of two clinical practice guidelines, i.e., the Guideline for Pharmacological Therapy of Schizophrenia and the Treatment Guidelines for Major Depressive Disorders, in Japan. Between 2016 and 2019, 782 psychiatrists belonging to 176 hospitals with psychiatric wards participated in the project and attended lectures on clinical practice guidelines. The proportions of guideline‐recommended treatments in 7405 patients with schizophrenia and 3794 patients with major depressive disorder at participating hospitals were compared between patients under the care of psychiatrists participating in the project and those not participating in the project. Clinical and prescribing data on the patients discharged from April to September each year from participating hospitals of the project were also analyzed. Results The proportions of three quality indicators (antipsychotic monotherapy regardless of whether other psychotropics medication, antipsychotic monotherapy without other psychotropics and no prescription of anxiolytics or hypnotics) for schizophrenia were higher among participating psychiatrists than among nonparticipating psychiatrists. As similar results were obtained in major depressive disorder, the effectiveness of the project for the dissemination of guideline‐recommended treatment has been replicated. Conclusion This strategy of providing education regarding the clinical guidelines for psychiatric disorders was effective in improving the treatment‐related behavior of psychiatrists. The use of this education‐based strategy might contribute to resolving the mental health treatment gap.</description><subject>Antipsychotic Agents - therapeutic use</subject><subject>Antipsychotics</subject><subject>Anxiolytics</subject><subject>Clinical medicine</subject><subject>clinical practice guideline</subject><subject>Clinical practice guidelines</subject><subject>Depression</subject><subject>Depressive Disorder, Major - drug therapy</subject><subject>dissemination</subject><subject>education</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypnotics</subject><subject>major depressive disorder</subject><subject>Mental depression</subject><subject>Mental disorders</subject><subject>Patients</subject><subject>Prospective Studies</subject><subject>Psychiatrists</subject><subject>Psychiatry</subject><subject>Psychotropic drugs</subject><subject>Psychotropic Drugs - therapeutic use</subject><subject>Regular</subject><subject>Schizophrenia</subject><subject>Schizophrenia - drug therapy</subject><issn>1323-1316</issn><issn>1440-1819</issn><issn>1440-1819</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1kc9uFSEYxSdGY2t14QsYEje6mBYGBhg3TXNT_ySNutA1YeCbOzRzYQSm5voavrCMtzbVREICCb9zvkNOVT0n-JSUdTYbf0poK-SD6pgwhmsiSfew3GlDa0IJP6qepHSNMaaUk8fVERVcMkHIcfXzchjAZBQGBHYxOrvgUYStjtb5LcoRdN6Bz2i7OAuT85DQECJKZnQ_wjxG8E4j7S2yMEdIadWXnUe4J-5h1DeuyMqYOe2LVufoUk5v0AXaLVN2pmBQbPNi90-rR4OeEjy7PU-qr28vv2ze11ef3n3YXFzVpm2ZrHtO2sHojnWMaNpz6BgllPaWMIlNRzG3Qres4y3XXDSCSCt6xrp-wD3mAuhJdX7wnZd-B3aNEPWk5uh2Ou5V0E79_eLdqLbhRpEyQXIsi8OrW4cYvi2Qstq5ZGCatIewJNVITpuOSb6iL_9Br8MSfflfoUSDBcFypV4fKBNDShGGuzQEq7VrVbpWv7su7Iv78e_IP-UW4OwAfHcT7P_vpD5vPh4sfwFWfbaj</recordid><startdate>202310</startdate><enddate>202310</enddate><creator>Hasegawa, Naomi</creator><creator>Yasuda, Yuka</creator><creator>Yasui‐Furukori, Norio</creator><creator>Yamada, Hisashi</creator><creator>Hori, Hikaru</creator><creator>Ichihashi, Kayo</creator><creator>Takaesu, Yoshikazu</creator><creator>Iida, Hitoshi</creator><creator>Muraoka, Hiroyuki</creator><creator>Kodaka, Fumitoshi</creator><creator>Iga, Jun‐ichi</creator><creator>Hashimoto, Naoki</creator><creator>Ogasawara, Kazuyoshi</creator><creator>Ohi, Kazutaka</creator><creator>Fukumoto, Kentaro</creator><creator>Numata, Shusuke</creator><creator>Tsuboi, Takashi</creator><creator>Usami, Masahide</creator><creator>Hishimoto, Akitoyo</creator><creator>Furihata, Ryuji</creator><creator>Kishimoto, Taishiro</creator><creator>Nakamura, Toshinori</creator><creator>Katsumoto, Eiichi</creator><creator>Ochi, Shinichiro</creator><creator>Nagasawa, Tatsuya</creator><creator>Atake, Kiyokazu</creator><creator>Kubota, Chika</creator><creator>Komatsu, Hiroshi</creator><creator>Yamagata, Hirotaka</creator><creator>Ide, Kenta</creator><creator>Takeshima, Masahiro</creator><creator>Kido, Mikio</creator><creator>Kikuchi, Saya</creator><creator>Okada, Tsuyoshi</creator><creator>Matsumoto, Junya</creator><creator>Miura, Kenichiro</creator><creator>Shimazu, Taichi</creator><creator>Inada, Ken</creator><creator>Watanabe, Koichiro</creator><creator>Hashimoto, Ryota</creator><general>John Wiley &amp; Sons Australia, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3722-7837</orcidid><orcidid>https://orcid.org/0000-0002-8253-8888</orcidid><orcidid>https://orcid.org/0000-0001-8311-7148</orcidid><orcidid>https://orcid.org/0000-0002-4414-3770</orcidid><orcidid>https://orcid.org/0000-0002-9169-3249</orcidid><orcidid>https://orcid.org/0000-0003-4228-3208</orcidid><orcidid>https://orcid.org/0000-0002-3073-4588</orcidid><orcidid>https://orcid.org/0000-0002-1145-9971</orcidid><orcidid>https://orcid.org/0000-0002-2746-1590</orcidid><orcidid>https://orcid.org/0000-0003-0614-7524</orcidid><orcidid>https://orcid.org/0000-0002-0736-7070</orcidid><orcidid>https://orcid.org/0000-0001-9417-4391</orcidid><orcidid>https://orcid.org/0000-0003-2263-3477</orcidid><orcidid>https://orcid.org/0000-0002-0809-2697</orcidid><orcidid>https://orcid.org/0000-0002-5941-4238</orcidid><orcidid>https://orcid.org/0000-0001-9577-9640</orcidid><orcidid>https://orcid.org/0000-0001-8129-4220</orcidid><orcidid>https://orcid.org/0000-0003-4409-3096</orcidid><orcidid>https://orcid.org/0000-0002-2240-5290</orcidid></search><sort><creationdate>202310</creationdate><title>Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study</title><author>Hasegawa, Naomi ; Yasuda, Yuka ; Yasui‐Furukori, Norio ; Yamada, Hisashi ; Hori, Hikaru ; Ichihashi, Kayo ; Takaesu, Yoshikazu ; Iida, Hitoshi ; Muraoka, Hiroyuki ; Kodaka, Fumitoshi ; Iga, Jun‐ichi ; Hashimoto, Naoki ; Ogasawara, Kazuyoshi ; Ohi, Kazutaka ; Fukumoto, Kentaro ; Numata, Shusuke ; Tsuboi, Takashi ; Usami, Masahide ; Hishimoto, Akitoyo ; Furihata, Ryuji ; Kishimoto, Taishiro ; Nakamura, Toshinori ; Katsumoto, Eiichi ; Ochi, Shinichiro ; Nagasawa, Tatsuya ; Atake, Kiyokazu ; Kubota, Chika ; Komatsu, Hiroshi ; Yamagata, Hirotaka ; Ide, Kenta ; Takeshima, Masahiro ; Kido, Mikio ; Kikuchi, Saya ; Okada, Tsuyoshi ; Matsumoto, Junya ; Miura, Kenichiro ; Shimazu, Taichi ; Inada, Ken ; Watanabe, Koichiro ; Hashimoto, Ryota</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5548-b615fca94941a3b6e943133bd1480c9306d7a549656a672718d7b449bf0b067e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antipsychotic Agents - therapeutic use</topic><topic>Antipsychotics</topic><topic>Anxiolytics</topic><topic>Clinical medicine</topic><topic>clinical practice guideline</topic><topic>Clinical practice guidelines</topic><topic>Depression</topic><topic>Depressive Disorder, Major - drug therapy</topic><topic>dissemination</topic><topic>education</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypnotics</topic><topic>major depressive disorder</topic><topic>Mental depression</topic><topic>Mental disorders</topic><topic>Patients</topic><topic>Prospective Studies</topic><topic>Psychiatrists</topic><topic>Psychiatry</topic><topic>Psychotropic drugs</topic><topic>Psychotropic Drugs - therapeutic use</topic><topic>Regular</topic><topic>Schizophrenia</topic><topic>Schizophrenia - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hasegawa, Naomi</creatorcontrib><creatorcontrib>Yasuda, Yuka</creatorcontrib><creatorcontrib>Yasui‐Furukori, Norio</creatorcontrib><creatorcontrib>Yamada, Hisashi</creatorcontrib><creatorcontrib>Hori, Hikaru</creatorcontrib><creatorcontrib>Ichihashi, Kayo</creatorcontrib><creatorcontrib>Takaesu, Yoshikazu</creatorcontrib><creatorcontrib>Iida, Hitoshi</creatorcontrib><creatorcontrib>Muraoka, Hiroyuki</creatorcontrib><creatorcontrib>Kodaka, Fumitoshi</creatorcontrib><creatorcontrib>Iga, Jun‐ichi</creatorcontrib><creatorcontrib>Hashimoto, Naoki</creatorcontrib><creatorcontrib>Ogasawara, Kazuyoshi</creatorcontrib><creatorcontrib>Ohi, Kazutaka</creatorcontrib><creatorcontrib>Fukumoto, Kentaro</creatorcontrib><creatorcontrib>Numata, Shusuke</creatorcontrib><creatorcontrib>Tsuboi, Takashi</creatorcontrib><creatorcontrib>Usami, Masahide</creatorcontrib><creatorcontrib>Hishimoto, Akitoyo</creatorcontrib><creatorcontrib>Furihata, Ryuji</creatorcontrib><creatorcontrib>Kishimoto, Taishiro</creatorcontrib><creatorcontrib>Nakamura, Toshinori</creatorcontrib><creatorcontrib>Katsumoto, Eiichi</creatorcontrib><creatorcontrib>Ochi, Shinichiro</creatorcontrib><creatorcontrib>Nagasawa, Tatsuya</creatorcontrib><creatorcontrib>Atake, Kiyokazu</creatorcontrib><creatorcontrib>Kubota, Chika</creatorcontrib><creatorcontrib>Komatsu, Hiroshi</creatorcontrib><creatorcontrib>Yamagata, Hirotaka</creatorcontrib><creatorcontrib>Ide, Kenta</creatorcontrib><creatorcontrib>Takeshima, Masahiro</creatorcontrib><creatorcontrib>Kido, Mikio</creatorcontrib><creatorcontrib>Kikuchi, Saya</creatorcontrib><creatorcontrib>Okada, Tsuyoshi</creatorcontrib><creatorcontrib>Matsumoto, Junya</creatorcontrib><creatorcontrib>Miura, Kenichiro</creatorcontrib><creatorcontrib>Shimazu, Taichi</creatorcontrib><creatorcontrib>Inada, Ken</creatorcontrib><creatorcontrib>Watanabe, Koichiro</creatorcontrib><creatorcontrib>Hashimoto, Ryota</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Psychiatry and clinical neurosciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hasegawa, Naomi</au><au>Yasuda, Yuka</au><au>Yasui‐Furukori, Norio</au><au>Yamada, Hisashi</au><au>Hori, Hikaru</au><au>Ichihashi, Kayo</au><au>Takaesu, Yoshikazu</au><au>Iida, Hitoshi</au><au>Muraoka, Hiroyuki</au><au>Kodaka, Fumitoshi</au><au>Iga, Jun‐ichi</au><au>Hashimoto, Naoki</au><au>Ogasawara, Kazuyoshi</au><au>Ohi, Kazutaka</au><au>Fukumoto, Kentaro</au><au>Numata, Shusuke</au><au>Tsuboi, Takashi</au><au>Usami, Masahide</au><au>Hishimoto, Akitoyo</au><au>Furihata, Ryuji</au><au>Kishimoto, Taishiro</au><au>Nakamura, Toshinori</au><au>Katsumoto, Eiichi</au><au>Ochi, Shinichiro</au><au>Nagasawa, Tatsuya</au><au>Atake, Kiyokazu</au><au>Kubota, Chika</au><au>Komatsu, Hiroshi</au><au>Yamagata, Hirotaka</au><au>Ide, Kenta</au><au>Takeshima, Masahiro</au><au>Kido, Mikio</au><au>Kikuchi, Saya</au><au>Okada, Tsuyoshi</au><au>Matsumoto, Junya</au><au>Miura, Kenichiro</au><au>Shimazu, Taichi</au><au>Inada, Ken</au><au>Watanabe, Koichiro</au><au>Hashimoto, Ryota</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study</atitle><jtitle>Psychiatry and clinical neurosciences</jtitle><addtitle>Psychiatry Clin Neurosci</addtitle><date>2023-10</date><risdate>2023</risdate><volume>77</volume><issue>10</issue><spage>559</spage><epage>568</epage><pages>559-568</pages><issn>1323-1316</issn><issn>1440-1819</issn><eissn>1440-1819</eissn><abstract>Aim This study aims to examine the real‐world effectiveness of education regarding clinical guidelines for psychiatric disorders using ‘the Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)’ project. Methods The EGUIDE project is a nationwide prospective implementation study of two clinical practice guidelines, i.e., the Guideline for Pharmacological Therapy of Schizophrenia and the Treatment Guidelines for Major Depressive Disorders, in Japan. Between 2016 and 2019, 782 psychiatrists belonging to 176 hospitals with psychiatric wards participated in the project and attended lectures on clinical practice guidelines. The proportions of guideline‐recommended treatments in 7405 patients with schizophrenia and 3794 patients with major depressive disorder at participating hospitals were compared between patients under the care of psychiatrists participating in the project and those not participating in the project. Clinical and prescribing data on the patients discharged from April to September each year from participating hospitals of the project were also analyzed. Results The proportions of three quality indicators (antipsychotic monotherapy regardless of whether other psychotropics medication, antipsychotic monotherapy without other psychotropics and no prescription of anxiolytics or hypnotics) for schizophrenia were higher among participating psychiatrists than among nonparticipating psychiatrists. As similar results were obtained in major depressive disorder, the effectiveness of the project for the dissemination of guideline‐recommended treatment has been replicated. Conclusion This strategy of providing education regarding the clinical guidelines for psychiatric disorders was effective in improving the treatment‐related behavior of psychiatrists. The use of this education‐based strategy might contribute to resolving the mental health treatment gap.</abstract><cop>Melbourne</cop><pub>John Wiley &amp; Sons Australia, Ltd</pub><pmid>37684711</pmid><doi>10.1111/pcn.13578</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-3722-7837</orcidid><orcidid>https://orcid.org/0000-0002-8253-8888</orcidid><orcidid>https://orcid.org/0000-0001-8311-7148</orcidid><orcidid>https://orcid.org/0000-0002-4414-3770</orcidid><orcidid>https://orcid.org/0000-0002-9169-3249</orcidid><orcidid>https://orcid.org/0000-0003-4228-3208</orcidid><orcidid>https://orcid.org/0000-0002-3073-4588</orcidid><orcidid>https://orcid.org/0000-0002-1145-9971</orcidid><orcidid>https://orcid.org/0000-0002-2746-1590</orcidid><orcidid>https://orcid.org/0000-0003-0614-7524</orcidid><orcidid>https://orcid.org/0000-0002-0736-7070</orcidid><orcidid>https://orcid.org/0000-0001-9417-4391</orcidid><orcidid>https://orcid.org/0000-0003-2263-3477</orcidid><orcidid>https://orcid.org/0000-0002-0809-2697</orcidid><orcidid>https://orcid.org/0000-0002-5941-4238</orcidid><orcidid>https://orcid.org/0000-0001-9577-9640</orcidid><orcidid>https://orcid.org/0000-0001-8129-4220</orcidid><orcidid>https://orcid.org/0000-0003-4409-3096</orcidid><orcidid>https://orcid.org/0000-0002-2240-5290</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1323-1316
ispartof Psychiatry and clinical neurosciences, 2023-10, Vol.77 (10), p.559-568
issn 1323-1316
1440-1819
1440-1819
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11488608
source Wiley Online Library - AutoHoldings Journals; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Open Access Titles of Japan; Wiley Online Library (Open Access Collection)
subjects Antipsychotic Agents - therapeutic use
Antipsychotics
Anxiolytics
Clinical medicine
clinical practice guideline
Clinical practice guidelines
Depression
Depressive Disorder, Major - drug therapy
dissemination
education
Hospitals
Humans
Hypnotics
major depressive disorder
Mental depression
Mental disorders
Patients
Prospective Studies
Psychiatrists
Psychiatry
Psychotropic drugs
Psychotropic Drugs - therapeutic use
Regular
Schizophrenia
Schizophrenia - drug therapy
title Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T08%3A02%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20education%20regarding%20treatment%20guidelines%20for%20schizophrenia%20and%20depression%20on%20the%20treatment%20behavior%20of%20psychiatrists:%20A%20multicenter%20study&rft.jtitle=Psychiatry%20and%20clinical%20neurosciences&rft.au=Hasegawa,%20Naomi&rft.date=2023-10&rft.volume=77&rft.issue=10&rft.spage=559&rft.epage=568&rft.pages=559-568&rft.issn=1323-1316&rft.eissn=1440-1819&rft_id=info:doi/10.1111/pcn.13578&rft_dat=%3Cproquest_pubme%3E2863294868%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2872071088&rft_id=info:pmid/37684711&rfr_iscdi=true